Bio-Techne Corporation Stock price

Equities

TECH

US09073M1045

Biotechnology & Medical Research

Market Closed - Nasdaq 04:30:00 2024-03-18 pm EDT 5-day change 1st Jan Change
71.88 USD -0.88% Intraday chart for Bio-Techne Corporation -4.33% -6.84%
Sales 2024 * 1.15B Sales 2025 * 1.25B Capitalization 11.3B
Net income 2024 * 177M Net income 2025 * 226M EV / Sales 2024 * 10 x
Net Debt 2024 * 187M Net cash position 2025 * 14.16M EV / Sales 2025 * 9.04 x
P/E ratio 2024 *
65.3 x
P/E ratio 2025 *
51 x
Employees 3,050
Yield 2024 *
0.45%
Yield 2025 *
0.45%
Free-Float 99.64%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.88%
1 week-4.33%
Current month-2.30%
1 month+0.38%
3 months-5.45%
6 months+1.00%
Current year-6.84%
More quotes
1 week
69.70
Extreme 69.7
74.68
1 month
69.62
Extreme 69.6216
78.75
Current year
64.97
Extreme 64.965
78.75
1 year
51.79
Extreme 51.79
89.91
3 years
51.79
Extreme 51.79
135.96
5 years
38.79
Extreme 38.7925
135.96
10 years
19.99
Extreme 19.9875
135.96
More quotes
Managers TitleAgeSince
Chief Executive Officer 57 18-04-29
Director of Finance/CFO 53 14-03-31
Chief Operating Officer 55 Jan. 07
Members of the board TitleAgeSince
Chairman 68 02-12-31
Director/Board Member 74 89-12-31
Director/Board Member 71 17-10-25
More insiders
Date Price Change Volume
24-03-18 71.88 -0.88% 1,004,049
24-03-15 72.52 +1.83% 1,749,508
24-03-14 71.22 -1.75% 1,380,383
24-03-13 72.49 -2.20% 995,750
24-03-12 74.12 -1.34% 1,105,193

Delayed Quote Nasdaq, March 18, 2024 at 04:30 pm EDT

More quotes
Bio-Techne Corporation specializes in the manufacture and marketing of products used in life science research. The group offers reagents and diagnostic tools for researchers, doctors, laboratories, pharmaceutical and biotechnology companies, etc. Net sales break down by family of products as follows: - biological and chemical reagents and analysis tools (74.3%): proteins, antibodies, molecules, culture serums, tools for cell work, tools for the study of proteins, immunoassay tools, etc.; - diagnostic and genomics products (25.7%): reagents and products used in blood analysis, nucleic acid analysis, tissue biopsy, gene analysis, cancer and genetic carrier screening, etc. Net sales are distributed geographically as follows: the United States (56.5%), the United Kingdom (4.4%), Europe/Middle East/Africa (19.4%), China (10%), Asia/Pacific (6.4%), and other (3.3%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
15
Last Close Price
71.88 USD
Average target price
80.32 USD
Spread / Average Target
+11.75%
Consensus
  1. Stock
  2. Equities
  3. Stock Bio-Techne Corporation - Nasdaq